D
David L. Earnest
Researcher at University of Arizona
Publications - 81
Citations - 3414
David L. Earnest is an academic researcher from University of Arizona. The author has contributed to research in topics: Bile acid & Irritable bowel syndrome. The author has an hindex of 29, co-authored 81 publications receiving 3275 citations.
Papers
More filters
Journal ArticleDOI
Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas
D.S. Alberts,Maria Elena Martinez,Denise J. Roe,Jose M. Guillen-Rodriguez,James R. Marshall,J B van Leeuwen,Mary E. Reid,Cheryl Ritenbaugh,Perla A. Vargas,A. B. Bhattacharyya,David L. Earnest,Richard E. Sampliner,Richard E. Sampliner +12 more
TL;DR: A randomized trial to determine whether dietary supplementation with wheat-bran fiber reduces the rate of recurrence of colorectal adenomas and found that it does not.
Journal Article
Chemoprevention of azoxymethane-induced colonic carcinogenesis by supplemental dietary ursodeoxycholic acid.
David L. Earnest,Hana Holubec,Ramesh K. Wali,Carolyn S. Jolley,Marc Bissonette,Achyut K. Bhattacharyya,Hemant K. Roy,Sharad Khare,Thomas A. Brasitus +8 more
TL;DR: The results of these studies demonstrated that none of the control rats fed the various diets injected with AOM-vehicle developed tumors, and demonstrate for the first time that supplemental dietary ursodeoxycholic acid is a chemopreventive agent in the AOM model of experimental colonic carcinogenesis.
Journal ArticleDOI
Different bile acids exhibit distinct biological effects: The tumor promoter deoxycholic acid induces apoptosis and the chemopreventive agent ursodeoxycholic acid inhibits cell proliferation
Jesse D. Martinez,Elias D. Stratagoules,Janna M. LaRue,Ashley A. Powell,Paul R. Gause,Mary T. Craven,Claire M. Payne,Marianne B. Powell,Eugene W. Gerner,David L. Earnest +9 more
TL;DR: Results indicate that different bile acids exhibit distinct biological activities and suggest that the cytotoxicity reported for DCA may be due to its capacity to induce apoptosis via a protein kinase C-dependent signaling pathway.
Journal ArticleDOI
Esophageal hypersensitivity may be a major cause of heartburn
Sheila Rodriguez-Stanley,Malcolm Robinson,David L. Earnest,Beverley Greenwood-Van Meerveld,Philip B. Miner +4 more
TL;DR: It is suggested that a significant subset of typical heartburn sufferers have a lower threshold for esophageal sensation and pain, which may influence options for pharmacological intervention in such subjects.
Journal ArticleDOI
Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis
Christopher J Black,Christopher J Black,Nicholas E Burr,Nicholas E Burr,Michael Camilleri,David L. Earnest,Eamonn Martin Quigley,Paul Moayyedi,Lesley A. Houghton,Alexander C. Ford,Alexander C. Ford +10 more
TL;DR: All drugs were found to be superior to placebo, but alosetron and ramosetrons appeared to be the most effective.